13F-HR filed by RHO CAPITAL PARTNERS INC
RHO CAPITAL PARTNERS INC filed this 13F-HR for the quarter ended 2020-06-30, filed 2020-08-07, with 5 holding rows worth $154,398,000.
- Accession
- 0001420506-20-000824
- Filer
- CIK 1020455
- Filed
- 2020-08-07
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2020
A holdings report, 5 entries on the cover page, a total value of $154,398,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $154,398,000 with VALUE read as thousands by filing date, 13F file number 028-05883. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| NGM BIOPHARMACEUTICALS INC | 62921N105 | COM | 3,766,666 | $74,354,000 | thousands by filing date | |
| CARA THERAPEUTICS INC | 140755109 | COM | 2,799,058 | $47,864,000 | thousands by filing date | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 796,458 | $18,637,000 | thousands by filing date | |
| LIVEXLIVE MEDIA INC | 53839L208 | COM NEW | 3,724,138 | $13,481,000 | thousands by filing date | |
| SENSEONICS HLDGS INC | 81727U105 | COM | 159,601 | $62,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-20-000824 | this filing | 2020-08-07 | acceptance time not in the bulk data set |